Meals are most challenging in the regulation of blood glucose levels (BGL) in diabetes mellitus type 1, whether it is automated, semi-automated or manually controlled. The common subcutaneous (SC) route for glucose sensing and insulin administration suffers from large latencies. This paper investigates the impact of glucose sensing and insulin absorption dynamics on the achievable glucose regulation when insulin boluses are triggered by a meal detection system. In silico patients from the academic version of the UVa/Padova simulator are studied. The sub-models of glucose sensing and insulin absorption are adjusted to allow simulations with different time delays and time constants. Meals are detected with published methods based on threshold...
Recent technological progress in insulin pumps and continuous glucose monitors (CGM) are enabling de...
This paper addresses the design of blood glucose control during the postprandial period for Type 1 d...
Diabetes currently affects about 9% of the world’s population, and causes loss or impairment of the ...
Current insulin therapy for patients with type 1 diabetes often results in high variability in blood...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
The regulation of blood glucose in Type-1 Diabetes Mellitus (T1DM) patient is being extensively inve...
In diabetes mellitus (DM) treatment, Continuous Glucose Monitoring (CGM) linked with insulin deliver...
Meals are one of the greatest challenges to glucose regulation in diabetes mellitus type 1. Several ...
The management of postprandial glucose excursions in type 1 diabetes has a major impact on overall g...
Item does not contain fulltextGlucose plasma measurements for diabetes patients are generally presen...
The relative roles of each component of the glucose (G)/insulin (I) system in determining after meal...
In patients with diabetes mellitus type 1, the pancreatic insulin production ceases, causing raise i...
Diabetes is a disease characterized by insufficient capacity to regulate the blood glucose level. In...
Estimation of future glucose concentrations is a crucial task for diabetes management. Predicted glu...
Recent technological progress in insulin pumps and continuous glucose monitors (CGM) are enabling de...
This paper addresses the design of blood glucose control during the postprandial period for Type 1 d...
Diabetes currently affects about 9% of the world’s population, and causes loss or impairment of the ...
Current insulin therapy for patients with type 1 diabetes often results in high variability in blood...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
The regulation of blood glucose in Type-1 Diabetes Mellitus (T1DM) patient is being extensively inve...
In diabetes mellitus (DM) treatment, Continuous Glucose Monitoring (CGM) linked with insulin deliver...
Meals are one of the greatest challenges to glucose regulation in diabetes mellitus type 1. Several ...
The management of postprandial glucose excursions in type 1 diabetes has a major impact on overall g...
Item does not contain fulltextGlucose plasma measurements for diabetes patients are generally presen...
The relative roles of each component of the glucose (G)/insulin (I) system in determining after meal...
In patients with diabetes mellitus type 1, the pancreatic insulin production ceases, causing raise i...
Diabetes is a disease characterized by insufficient capacity to regulate the blood glucose level. In...
Estimation of future glucose concentrations is a crucial task for diabetes management. Predicted glu...
Recent technological progress in insulin pumps and continuous glucose monitors (CGM) are enabling de...
This paper addresses the design of blood glucose control during the postprandial period for Type 1 d...
Diabetes currently affects about 9% of the world’s population, and causes loss or impairment of the ...